Uploaded December 2014 | Updated September 2026, 1 hour ago
The smartphone revolution, 3D printing and the omnipresence of sensors are impacting healthcare in a major way: how it is prescribed, delivered, and checked. Over the next few years, key innovations are going to hit the consumer market – and we’re bringing some of these innovators to LeWeb. Our session on the Future of Healthcare will feature a group of pioneers in neurostimulation, microbiome exploration and preventive medicine who introduce the audience to the latest developments in their respective domains.
Our curator is Jeff Clavier, the Managing Director of SoftTech VC – one of the most well known seed stage firms in Silicon Valley. Jeff was a seed investor in fitness tracker Fitbit, BetterDoctor and has made Consumer Healthcare one of the key investment sectors of his latest Fund, $85M SoftTech VC IV.
We will then hear from Dr. Dan Chao, CEO, Halo NeuroScience, Sean Duffy, CEO, OmadaHealth and Jessica Richman, CEO, uBiome. After presenting their companies, they will join Dr. Kraft on a panel to discuss the healthcare innovation, funding environment and regulatory constraints that startups face when bringing products to market.
The smartphone revolution, 3D printing and the omnipresence of sensors are impacting healthcare in a major way: how it is prescribed, delivered, and checked. Over the next few years, key innovations are going to hit the consumer market – and we’re bringing some of these innovators to LeWeb. Our session on the Future of Healthcare will feature a group of pioneers in neurostimulation, microbiome exploration and preventive medicine who introduce the audience to the latest developments in their respective domains.
Our curator is Jeff Clavier, the Managing Director of SoftTech VC – one of the most well known seed stage firms in Silicon Valley. Jeff was a seed investor in fitness tracker Fitbit, BetterDoctor and has made Consumer Healthcare one of the key investment sectors of his latest Fund, $85M SoftTech VC IV.
We will then hear from Dr. Dan Chao, CEO, Halo NeuroScience, Sean Duffy, CEO, OmadaHealth and Jessica Richman, CEO, uBiome. After presenting their companies, they will join Dr. Kraft on a panel to discuss the healthcare innovation, funding environment and regulatory constraints that startups face when bringing products to market.
